WO2003032895A3 - Methods and pharmaceutical compositions for stimulating the immune system and/or treating cancer - Google Patents

Methods and pharmaceutical compositions for stimulating the immune system and/or treating cancer Download PDF

Info

Publication number
WO2003032895A3
WO2003032895A3 PCT/IL2002/000803 IL0200803W WO03032895A3 WO 2003032895 A3 WO2003032895 A3 WO 2003032895A3 IL 0200803 W IL0200803 W IL 0200803W WO 03032895 A3 WO03032895 A3 WO 03032895A3
Authority
WO
WIPO (PCT)
Prior art keywords
treating cancer
stimulating
methods
pharmaceutical compositions
immune system
Prior art date
Application number
PCT/IL2002/000803
Other languages
French (fr)
Other versions
WO2003032895A2 (en
Inventor
Abraham Novogrodsky
Original Assignee
Notox Ltd
Abraham Novogrodsky
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Notox Ltd, Abraham Novogrodsky filed Critical Notox Ltd
Publication of WO2003032895A2 publication Critical patent/WO2003032895A2/en
Publication of WO2003032895A3 publication Critical patent/WO2003032895A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds

Abstract

A method of treating a disease, syndrome or condition, in which immune stimulation is beneficial and/or treating cancer. The method comprises administering to a subject in need thereof at least one agent in an amount so as to induce H2O2 generation at a concentration effective in inducing immune stimulation and or providing cancer therapy.
PCT/IL2002/000803 2001-10-17 2002-10-02 Methods and pharmaceutical compositions for stimulating the immune system and/or treating cancer WO2003032895A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32954801P 2001-10-17 2001-10-17
US60/329,548 2001-10-17

Publications (2)

Publication Number Publication Date
WO2003032895A2 WO2003032895A2 (en) 2003-04-24
WO2003032895A3 true WO2003032895A3 (en) 2005-12-08

Family

ID=23285920

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2002/000803 WO2003032895A2 (en) 2001-10-17 2002-10-02 Methods and pharmaceutical compositions for stimulating the immune system and/or treating cancer

Country Status (1)

Country Link
WO (1) WO2003032895A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008004100A1 (en) * 2008-01-11 2009-07-16 Westfälische Wilhelms-Universität Münster Körperschaft des öffentlichen Rechts New metallocene compounds are estrogen receptor modulators useful e.g. to treat preferably cancer, manic disorder, gynecomastia and/or female infertility, and to prevent mamma carcinoma

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2839552A (en) * 1955-08-08 1958-06-17 Ethyl Corp Cyclomatic manganese compounds
US3960911A (en) * 1973-11-21 1976-06-01 Frisons Limited Ferrocene compounds and preparation
US5167948A (en) * 1987-08-07 1992-12-01 Mallinckrodt Medical, Inc. Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2839552A (en) * 1955-08-08 1958-06-17 Ethyl Corp Cyclomatic manganese compounds
US3960911A (en) * 1973-11-21 1976-06-01 Frisons Limited Ferrocene compounds and preparation
US5167948A (en) * 1987-08-07 1992-12-01 Mallinckrodt Medical, Inc. Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound

Also Published As

Publication number Publication date
WO2003032895A2 (en) 2003-04-24

Similar Documents

Publication Publication Date Title
IL267381A (en) Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
WO2003094836A3 (en) Methods and products for enhancing immune responses using imidazoquinoline compounds
WO2004004661A3 (en) Boroproline compound combination therapy
UA99094C2 (en) Method for the treatment of patients with autoantibody positive disease
WO2005051429A3 (en) Targeted conjugates with a modified saccharide linker
WO2004045593A3 (en) Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
WO2003092617A3 (en) Combinations for the treatment of inflammatory skin disorders
AU4258101A (en) Combination therapies with vascular damaging activity
IL173481A0 (en) Polysaccharide double-layer microcapsules as carriers for biologically active substance oral administration
CA2534577A1 (en) Method for promoting bone growth
WO2008045378A3 (en) Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin
WO2000040229A3 (en) Synergistic tumorcidal response induced by histamine
EA200801731A1 (en) COMPOSITIONS AND METHODS OF TREATMENT OF TROBMOCYTHEMIA
WO2004007676A3 (en) Combination therapy for the treatment of neoplasms
PT1237562E (en) PROCESS OF PREPARATION OF MYCANYAN EXTRACTS CONTAINING MICANOLIDE AND DIHYDROMICANOLID AND USES IN THE TREATMENT OF PROLIFERATIVE DISEASES
WO2003032895A3 (en) Methods and pharmaceutical compositions for stimulating the immune system and/or treating cancer
WO2002076393A3 (en) Antiagionecic, antitumor, chemopreventative agents
TW200501958A (en) A therapeutic agent for treating a behavioral disorder
FR2786699B1 (en) MEDICINE, IN PARTICULAR FOR PREVENTING OR TREATING SEXUAL DYSFUNCTIONS
MXPA05008879A (en) A combined therapy comprising an indolopyrrolocarbazole derivative and another antitumor agent.
WO2002076405A3 (en) Compositions and methods of treatment of ulcerating diseases, burns, and related conditions
UA34303A (en) Method for treating myocarditis
MXPA05010173A (en) Anti-cancer virus desensitization method.
WO2003059334A3 (en) Gemcitabine in the treatment of smallpox
UA31548A (en) The method for prophilaxis and treatment of childs somatic diseases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MK MN MW MX MZ NO NZ OM PH PT RO RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP